Bandaram Pharma Packtech Rights Issue 2023 FAQ's

₹9.00 Crores | Listing at BSE | Wed, Jul 12, 2023 - Thu, Jul 20, 2023

Bandaram Pharma Packtech Limited Rights Issue Date 2026 & Price FAQs

The timetable for Bandaram Pharma Packtech Limited Rights Issue is as follows:

Last Date for credit of Rights Entitlements
Last Date for renunciation of Rights EntitlementsMon, Jul 17, 2023
Issue Opening DateWed, Jul 12, 2023
Issue Closing DateThu, Jul 20, 2023
Date of Allotment (on or about)Wed, Jul 26, 2023
Date of Credit (on or about)Mon, Jul 31, 2023
Date of Listing (on or about)Thu, Aug 3, 2023

Bandaram Pharma Packtech Rights Issue 2023 price is set at ₹10 per share. The Bandaram Pharma Packtech Rights Issue 2023 opens on Wed, Jul 12, 2023, and closes on Thu, Jul 20, 2023, for the subscription.

The allotment of Bandaram Pharma Packtech Rights Issue 2023 is expected to happen on or about July 26, 2023 as per the issue schedule.

Bandaram Pharma Packtech Rights Issue 2023 listing date is 2023-08-02T00:00:00.000Z.

The credit of Bandaram Pharma Packtech Rights Issue 2023 in Demat account is expected on or about July 31, 2023 as per the issue schedule.

Objects of the Issue:

The company proposes to utilize the net proceeds from the issue towards funding the following objects:

  1. Conversion of unsecured loans availed by our Company from the Promoters;
  2. Investment in our Subsidiary, "VSR Paper & Packaging Limited" for augmentation of funding requirements for its business activities.
  3. Acquisition of Companies to achieve inorganic growth.
  4. General Corporate Purposes

It is difficult to predict the exact listing price of Bandaram Pharma Packtech Limited Rights Issue shares. The price depends on the demand and supply of the company's shares on the day of listing.

We do not provide Rights Issue recommendations. However, we share a lot of information about Bandaram Pharma Packtech Limited which could help you with questions like whether to subscribe or not. Consider reading Bandaram Pharma Packtech Limited reviews and analysis from experts posted on the Rights Issue detail page.